XP is an autosomal recessive condition ... Around 25% of people with XP will additionally develop neurological symptoms associated with the disorder, likely because of damage to DNA in nerve cells in ...

Consultant Neurologist Professor Tim Lynch acknowledged “there is something” that is increasing the frequency of the disease.

The slow loss of memory, thinking, and independence that defines Alzheimer’s disease continues to affect millions worldwide.

According to DealPulse’s M&A database, which harnesses both AI and attorneys to digest the granular deal points of publicly announced transactions, Regulus is advised by Latham & Watkins LLP, while ...

Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS acquisition.